Mindfulness practice for patients with endometrial and cervical cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the effects of using the Headspace smartphone application for mindfulness on patients diagnosed with endometrial or cervical cancer who are preparing for surgery or chemoradiation. Participants will be randomized to either use the app or not prior to their treatment. The goal is to assess whether mindfulness can help manage stress, anxiety, and improve quality of life while potentially reducing opioid use. The study builds on existing literature that suggests mindfulness can have positive effects on cancer patients' well-being.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* New diagnosis of either 1) endometrial cancer undergoing surgery or 2) cervical cancer undergoing chemo-sensitizing radiation
* Access to a smartphone

Exclusion Criteria:

* Non-English speaking
* No access to smartphone
* Current use of Headspace application

Where it's running

• Saint Louis University
  St Louis, Missouri, United States Recruiting

Study contacts

• Principal investigator: Shannon Grabosch, MD — St. Louis University
• Study coordinator: Shannon Grabosch, MD
• Email: shannon.grabosch@health.slu.edu
• Phone: 3147818605

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Radiotherapy for gynecologic cancer with up to 10 metastatic sites

  This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.

  Recruiting Affidea Nu-med Center of Oncological DIagnostics and Therapy · Zamość · NCT07883798

• Using Belzutifan to treat recurrent clear cell ovarian carcinoma

  This study is testing if a new targeted therapy called Belzutifan can help people with recurrent clear cell ovarian cancer feel better and manage their disease.

  Recruiting at 2 sites Phase 2 Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT06677190

• One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy

  This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07895212

• Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy

  The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.

  Recruiting The Second People's Hospital of Huai'an · Huai'an, Jiangsu · NCT07860203

• First-in-human test of HH160 in people with advanced solid tumors

  HH160 is being tested to see if it is safe and how it behaves in the body, to see if it has early signs of helping various advanced cancers in adults.

  Recruiting at 3 sites Phase 1 Huahui Health · Waratah, New South Wales and 2 other locations · NCT07623369

• Online adaptive radiotherapy vs standard radiotherapy after surgery for cervical or endometrial cancer

  A national, multi-center study will test whether online adaptive radiotherapy can reduce side effects and improve quality of life compared with standard radiotherapy in adults after surgery for cervical or endometrial cancer.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07584161

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.